Cargando…

Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen

Wellens syndrome is a comprehensive electrocardiographic (ECG) diagnosis that combines medical history with characteristic ECG changes. These changes, characterized by biphasic T-wave inversions or symmetric and deep T-wave inversions in the anterior precordial leads, often indicate that the left an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xufei, Geng, Xuhong, Gong, Xiaohong, Yin, Xi, Chen, Yongzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146116/
https://www.ncbi.nlm.nih.gov/pubmed/37115080
http://dx.doi.org/10.1097/MD.0000000000033599
_version_ 1785034503907966976
author Liang, Xufei
Geng, Xuhong
Gong, Xiaohong
Yin, Xi
Chen, Yongzhen
author_facet Liang, Xufei
Geng, Xuhong
Gong, Xiaohong
Yin, Xi
Chen, Yongzhen
author_sort Liang, Xufei
collection PubMed
description Wellens syndrome is a comprehensive electrocardiographic (ECG) diagnosis that combines medical history with characteristic ECG changes. These changes, characterized by biphasic T-wave inversions or symmetric and deep T-wave inversions in the anterior precordial leads, often indicate that the left anterior descending coronary artery is at a high risk of severe stenosis. Chemotherapy-related cardiovascular toxicity refers to damage to the cardiovascular system caused by chemotherapeutic drugs, which is unpredictable and may occur during or after chemotherapy. PATIENT CONCERNS: In this case report, a 41-year-old male patient with cholangiocarcinoma received sequential adjuvant chemotherapy with gemcitabine/nanoparticle albumin–bound paclitaxel and gemcitabine/cisplatin. This patient presented with recurrent brief chest pain episodes after the third dose of gemcitabine/cisplatin, and the characteristic T-wave morphological changes were captured in routine ECG monitoring prior to the 6th dose. DIAGNOSES: Acute coronary syndrome due to chemotherapy-related cardiovascular toxicity was diagnosed on the basis of characteristic ECG changes. INTERVENTIONS: The patient underwent coronary angiography, which revealed diffuse stenosis of up to 95% in the middle segment of the left anterior descending coronary artery. Stents were implanted in the stenotic segment for vascular reconstruction. OUTCOMES: The patient’s chest pain was completely resolved, and electrocardiography returned to normal. LESSONS: Cardiovascular toxicity during chemotherapy in patients with cancer may be life threatening. This rare case highlights the importance of identifying the characteristic ECG pattern of the Wellens syndrome by monitoring electrocardiography during chemotherapy. Immediate and accurate identification of the morphological ECG features of Wellens syndrome with a slight elevation of the ST-segment is related to patient prognosis.
format Online
Article
Text
id pubmed-10146116
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101461162023-04-29 Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen Liang, Xufei Geng, Xuhong Gong, Xiaohong Yin, Xi Chen, Yongzhen Medicine (Baltimore) 3400 Wellens syndrome is a comprehensive electrocardiographic (ECG) diagnosis that combines medical history with characteristic ECG changes. These changes, characterized by biphasic T-wave inversions or symmetric and deep T-wave inversions in the anterior precordial leads, often indicate that the left anterior descending coronary artery is at a high risk of severe stenosis. Chemotherapy-related cardiovascular toxicity refers to damage to the cardiovascular system caused by chemotherapeutic drugs, which is unpredictable and may occur during or after chemotherapy. PATIENT CONCERNS: In this case report, a 41-year-old male patient with cholangiocarcinoma received sequential adjuvant chemotherapy with gemcitabine/nanoparticle albumin–bound paclitaxel and gemcitabine/cisplatin. This patient presented with recurrent brief chest pain episodes after the third dose of gemcitabine/cisplatin, and the characteristic T-wave morphological changes were captured in routine ECG monitoring prior to the 6th dose. DIAGNOSES: Acute coronary syndrome due to chemotherapy-related cardiovascular toxicity was diagnosed on the basis of characteristic ECG changes. INTERVENTIONS: The patient underwent coronary angiography, which revealed diffuse stenosis of up to 95% in the middle segment of the left anterior descending coronary artery. Stents were implanted in the stenotic segment for vascular reconstruction. OUTCOMES: The patient’s chest pain was completely resolved, and electrocardiography returned to normal. LESSONS: Cardiovascular toxicity during chemotherapy in patients with cancer may be life threatening. This rare case highlights the importance of identifying the characteristic ECG pattern of the Wellens syndrome by monitoring electrocardiography during chemotherapy. Immediate and accurate identification of the morphological ECG features of Wellens syndrome with a slight elevation of the ST-segment is related to patient prognosis. Lippincott Williams & Wilkins 2023-04-25 /pmc/articles/PMC10146116/ /pubmed/37115080 http://dx.doi.org/10.1097/MD.0000000000033599 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3400
Liang, Xufei
Geng, Xuhong
Gong, Xiaohong
Yin, Xi
Chen, Yongzhen
Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen
title Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen
title_full Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen
title_fullStr Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen
title_full_unstemmed Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen
title_short Wellens syndrome during chemotherapy for cholangiocarcinoma: A case report of cardiovascular toxicity associated with gemcitabine-containing regimen
title_sort wellens syndrome during chemotherapy for cholangiocarcinoma: a case report of cardiovascular toxicity associated with gemcitabine-containing regimen
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146116/
https://www.ncbi.nlm.nih.gov/pubmed/37115080
http://dx.doi.org/10.1097/MD.0000000000033599
work_keys_str_mv AT liangxufei wellenssyndromeduringchemotherapyforcholangiocarcinomaacasereportofcardiovasculartoxicityassociatedwithgemcitabinecontainingregimen
AT gengxuhong wellenssyndromeduringchemotherapyforcholangiocarcinomaacasereportofcardiovasculartoxicityassociatedwithgemcitabinecontainingregimen
AT gongxiaohong wellenssyndromeduringchemotherapyforcholangiocarcinomaacasereportofcardiovasculartoxicityassociatedwithgemcitabinecontainingregimen
AT yinxi wellenssyndromeduringchemotherapyforcholangiocarcinomaacasereportofcardiovasculartoxicityassociatedwithgemcitabinecontainingregimen
AT chenyongzhen wellenssyndromeduringchemotherapyforcholangiocarcinomaacasereportofcardiovasculartoxicityassociatedwithgemcitabinecontainingregimen